Towards Healthcare
Coronary Stent Market Size Uplifts USD 13.27 Bn by 2034

Coronary Stent Market Size, Trends, Regulatory Landscape and Competitive Strategies

According to market projections, the global coronary stent market, valued at USD 9.31 billion in 2024, is anticipated to reach USD 13.27 billion by 2034, growing at a CAGR of 3.6% over the next decade. The market focuses on devices used to open narrowed heart arteries, improving blood flow and reducing heart attack risk. Growth is driven by rising heart disease cases, aging populations, and advances in drug-eluting stents. Key players innovate for better safety, durability, and effectiveness.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Coronary Stent Market Assessment

  • Overview
  • Global Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Bare Metal Stents (BMS)
    • Drug-eluting Stents (DES)
    • Bioresorbable Scaffold System (BRS)
    • Drug-eluting Balloons (DEB)
  • Global Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by End Use (2021 – 2033)
    • Hospitals & Ambulatory Surgical Centers
    • Specialty Clinics
    • Others
  • Global Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Middle East and Africa
    • South America

North America Coronary Stent Market Assessment

  • Overview
  • North America Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Bare Metal Stents (BMS)
    • Drug-eluting Stents (DES)
    • Bioresorbable Scaffold System (BRS)
    • Drug-eluting Balloons (DEB)
  • North America Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by End Use (2021 – 2033)
    • Hospitals & Ambulatory Surgical Centers
    • Specialty Clinics
    • Others

Europe Coronary Stent Market Assessment

  • Overview
  • Europe Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Bare Metal Stents (BMS)
    • Drug-eluting Stents (DES)
    • Bioresorbable Scaffold System (BRS)
    • Drug-eluting Balloons (DEB)
  • Europe Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by End Use (2021 – 2033)
    • Hospitals & Ambulatory Surgical Centers
    • Specialty Clinics
    • Others

Asia Pacific Coronary Stent Market Assessment

  • Overview
  • Asia Pacific Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Bare Metal Stents (BMS)
    • Drug-eluting Stents (DES)
    • Bioresorbable Scaffold System (BRS)
    • Drug-eluting Balloons (DEB)
  • Asia Pacific Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by End Use (2021 – 2033)
    • Hospitals & Ambulatory Surgical Centers
    • Specialty Clinics
    • Others

Middle East and Africa Coronary Stent Market Assessment

  • Overview
  • Middle East and Africa Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Bare Metal Stents (BMS)
    • Drug-eluting Stents (DES)
    • Bioresorbable Scaffold System (BRS)
    • Drug-eluting Balloons (DEB)
  • Middle East and Africa Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by End Use (2021 – 2033)
    • Hospitals & Ambulatory Surgical Centers
    • Specialty Clinics
    • Others

South America Coronary Stent Market Assessment

  • Overview
  • South America Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Bare Metal Stents (BMS)
    • Drug-eluting Stents (DES)
    • Bioresorbable Scaffold System (BRS)
    • Drug-eluting Balloons (DEB)
  • South America Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by End Use (2021 – 2033)
    • Hospitals & Ambulatory Surgical Centers
    • Specialty Clinics
    • Others

Company Profiles

  • Biotronik SE & Co. KG
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Cook
  • Terumo Corporation
  • Abbott
  • BD
  • MicroPort Scientific Corporation
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Medtronic

Conclusion & Recommendations

  • Insight Code: 5152
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: May 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

Aging population with increased CAD risk, Rising diabetes rates, a major CAD risk factor, Growing demand for minimally invasive procedures like stenting.

Asia Pacific is a high-growth market due to economic development and rising healthcare access. North America remains dominant but faces cost-effectiveness pressures. Emerging markets in South America and Middle East & Africa offer future potential.

Focus on bioresorbable stents that dissolve over time. Advancements in materials and drug delivery mechanisms for improved efficacy. Emphasis on cost-effective stents with long-term durability.

National Institute of Health, British Health Foundation and World Health Organization.